These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24431422)

  • 1. Liver X receptors and atherosclerosis: it is not all cholesterol.
    Ignatova ID; Schulman IG
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):242-3. PubMed ID: 24431422
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel partial agonist of liver X receptor α (LXRα) via screening.
    Li N; Wang X; Zhang J; Liu C; Li Y; Feng T; Xu Y; Si S
    Biochem Pharmacol; 2014 Dec; 92(3):438-47. PubMed ID: 25450668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group X secretory phospholipase A2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages.
    Shridas P; Bailey WM; Gizard F; Oslund RC; Gelb MH; Bruemmer D; Webb NR
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2014-21. PubMed ID: 20844270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of statins on ABCA1 and ABCG1 expression in human macrophages is influenced by cellular cholesterol levels and extent of differentiation.
    Wong J; Quinn CM; Gelissen IC; Jessup W; Brown AJ
    Atherosclerosis; 2008 Jan; 196(1):180-189. PubMed ID: 17466310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
    Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
    Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
    Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unsaturated fatty acids repress expression of ATP binding cassette transporter A1 and G1 in RAW 264.7 macrophages.
    Ku CS; Park Y; Coleman SL; Lee J
    J Nutr Biochem; 2012 Oct; 23(10):1271-6. PubMed ID: 22209005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver X receptor activation attenuates plaque formation and improves vasomotor function of the aortic artery in atherosclerotic ApoE(-/-) mice.
    Chen J; Zhao L; Sun D; Narsinh K; Li C; Zhang Z; Qi S; Wei G; Li W; Guo W; Cao F
    Inflamm Res; 2012 Dec; 61(12):1299-307. PubMed ID: 22833121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA reductase inhibitors, simvastatin and atorvastatin, downregulate ABCG1-mediated cholesterol efflux in human macrophages.
    Wang W; Song W; Wang Y; Chen L; Yan X
    J Cardiovasc Pharmacol; 2013 Jul; 62(1):90-8. PubMed ID: 23846804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate.
    Matsuo K; Yamamoto S; Wakamatsu T; Takahashi Y; Kawamura K; Kaneko Y; Goto S; Kazama JJ; Narita I
    Toxins (Basel); 2015 Aug; 7(8):3155-66. PubMed ID: 26287243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCA1 contributes to macrophage deposition of extracellular cholesterol.
    Jin X; Freeman SR; Vaisman B; Liu Y; Chang J; Varsano N; Addadi L; Remaley A; Kruth HS
    J Lipid Res; 2015 Sep; 56(9):1720-6. PubMed ID: 26203076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.
    Verschuren L; de Vries-van der Weij J; Zadelaar S; Kleemann R; Kooistra T
    J Lipid Res; 2009 Feb; 50(2):301-11. PubMed ID: 18757914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of ABCA1 and ABCG1 gene expressions in the remodeling mouse hippocampus after entorhinal cortex lesion and liver-X receptor agonist treatment.
    Jasmin SB; Pearson V; Lalonde D; Domenger D; Théroux L; Poirier J
    Brain Res; 2014 May; 1562():39-51. PubMed ID: 24661912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCG1-mediated generation of extracellular cholesterol microdomains.
    Freeman SR; Jin X; Anzinger JJ; Xu Q; Purushothaman S; Fessler MB; Addadi L; Kruth HS
    J Lipid Res; 2014 Jan; 55(1):115-27. PubMed ID: 24212237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCA1 upregulating apolipoproein M expression mediates via the RXR/LXR pathway in HepG2 cells.
    Di D; Wang Z; Liu Y; Luo G; Shi Y; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
    Biochem Biophys Res Commun; 2012 Apr; 421(1):152-6. PubMed ID: 22516753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of Abcg1 results in decreased plasma HDL cholesterol levels and increased biliary cholesterol secretion in mice fed a high cholesterol diet.
    Wiersma H; Nijstad N; de Boer JF; Out R; Hogewerf W; Van Berkel TJ; Kuipers F; Tietge UJ
    Atherosclerosis; 2009 Sep; 206(1):141-7. PubMed ID: 19339012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144.
    Ramírez CM; Rotllan N; Vlassov AV; Dávalos A; Li M; Goedeke L; Aranda JF; Cirera-Salinas D; Araldi E; Salerno A; Wanschel A; Zavadil J; Castrillo A; Kim J; Suárez Y; Fernández-Hernando C
    Circ Res; 2013 Jun; 112(12):1592-601. PubMed ID: 23519695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X receptors inhibit macrophage proliferation through downregulation of cyclins D1 and B1 and cyclin-dependent kinases 2 and 4.
    Pascual-García M; Carbó JM; León T; Matalonga J; Out R; Van Berkel T; Sarrias MR; Lozano F; Celada A; Valledor AF
    J Immunol; 2011 Apr; 186(8):4656-67. PubMed ID: 21398609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
    Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
    Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.